Oligometastasis: Defining, targeting, and optimising local control in the era of effective systemic therapy
The management of oligometastatic disease is rapidly evolving with the increasing effectiveness of systemic therapies. This symposium will explore current concepts and controversies in defining oligometastatic disease and integrating local treatments into multidisciplinary care. Experts will discuss the biological and clinical limits of the oligometastatic state, the role of prostate and metastasis-directed therapy in low-volume metastatic prostate cancer in the ARPI era, the value of local treatment for primary and metastatic breast cancer, and strategies for combining local and systemic therapies in lung oligometastatic disease. The session will provide practical insights into optimising patient selection and treatment sequencing
Symposium
Education